Manufacture

Our latest news roundup reports on dysfunction observed in edited blood stem cells, and RFK Jr’s support for experimental treatments.

Stanford University researchers explore how zinc fingers can enhance gene therapy.

The challenges of developing optimized biologics formulations are well known, but the good news is that the industry continues to develop solutions.

Is the complexity of the fill-finish process under appreciated in pharma manufacturing? Four experts discuss why it’s important to get it right.

Our latest news roundup reports on a cell therapy facility expansion in Princeton, a magnet to capture T cells, and more.

Work from the lab of Luigi Naldini identifies postnatal window for in vivo gene editing, without the need for conditioning or transplantation

Researchers explore how different preconditioning approaches can impact the performance of dendritic cell vaccines for cancer.

Patient fatality reported in clinical trial for investigational gene therapy for Danon disease.

Mistakes in fill-finish can lead to lost batches, lost profits, and increased regulatory scrutiny. Four experts discuss.

Our latest news roundup reports on a gene therapy for Duchenne muscular dystrophy that can be re-dosed, a free toolkit for gene delivery, and more.